Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$BYND, $BNTX, $CURLF, $LMT, $LULU, $NEM, $RGLD, $SCCO, $VRTX

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Wednesday, 20 May, as follows:

Beyond Meat Inc. (NASDAQ:BYND) was started with a Buy rating and a 173 price target at BTIG.

BioNTech S.E. (NASDAQ:BNTX) was upgraded to Buy from Neutral and its price target was raised to 69 from 48 at HC Wainwright.

Curaleaf Holdings Inc. (NASDAQ:CURLF) was reiterated as Buy and its price target was raised to 10 from 6 at Needham.

General Dynamics Corp. (NYSE:GD) was started with a Buy rating and a 188 price target at Seaport Global.

Lockheed Martin Corp. (NYSE:LMT) was started with a Buy rating and a $435 price target at Seaport Global.

Lululemon Athletica Inc. (NASDAQ:LULU) was reiterated as Buy and its price target was raised to 290 from 256 at B. Riley FBR.

Newmont Corp. (NYSE:NEM) was reiterated as Buy and its price target was raised to 97 from 96 at B. Riley FBR.

Royal Gold Inc. (NASDAQ:RGLD) was reiterated as Buy and the price target was raised to 151 from 150 at B Riley FBR.

Southern Copper Corp. (NYSE:SCCO) was reiterated as Buy and its price target was raised to 40 from 38 at UBS.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX): the champ of cystic fibrosis is about to repeat another year of 37% revenue growth. Shares have a consensus price target of 283.91.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.